Clinical effectiveness of prednisolone oral administration for esophageal stricture after endoscopic submucosal dissection for esophageal neoplasms.

Clinical effectiveness of prednisolone oral administration for esophageal stricture after endoscopic submucosal dissection for esophageal neoplasms. - Post-ESD esophageal strictures and prednisolone

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003259

Enrollment

120

Registered

2010-02-26

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal neoplasms

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: esopageal neoplasms that fuifil the ESD criteria with resection over 3/4 circumference

Exclusion criteria

Exclusion criteria: ESD failure severe complications and adverse events

Design outcomes

Primary

Measure	Time frame
endoscopic assessment of esophageal passage symptoms	—

Secondary

Measure	Time frame
times of preventive endoscopic balloon dilatation	—

Countries

Japan

Contacts

Public ContactHajime Isomoto

Nagasaki University Hospital Department of Endoscopy

hajimei-ngs@umin.ac.jp095-819-7489

Outcome results